On September 18, 2024, Sulzer successfully priced the offering of its CHF 250 million 1.7725% bonds. Homburger acted as counsel to Sulzer with a team consisting of Benjamin Leisinger and Eduard De Zordi (both capital markets). About the bond issuance The bond, which will be listed on the SIX Swiss Exchange, has a term of […]
Swiss Life, advised by Walder Wyss, has successfully placed a EUR 500 million dated subordinated bond, first callable in October 2034. The bonds were placed with investors in the European market. The proceeds will be used for
Borel & Barbey advised In Extenso, an accounting firm in France, on its acquisition of a majority stake in Fidexpert Group, a player in fiduciary services in French-speaking Switzerland. This transaction aligns with In Extenso’
Neo Medical, a Swiss technology company specializing in spine surgery, has announced the successful completion of a strategic equity investment, including the conversion of existing shareholder loans. The financing round was led by Gyrus Capital,
Sandoz, a global leader in the generics and biosimilars markets successfully placed EUR 600 million senior guaranteed Eurobonds listed on the SIX Swiss Exchange, advised by Advestra. The bonds are issued by Sandoz Finance B.V.
On 11 September 2024, 2024, Bank WIR Genossenschaft successfully completed the public offering of its participation certificates with a transaction volume of CHF 30 million, advised by Kellerhals Carrard. The participation certificates are governed by Swiss law and have
Homburger advised Equinix, a digital infrastructure company, in connection with the issuance of CHF 100 million 1.5575% Green Bonds due in 2029. Homburger team The Homburger team was led by Alexander Wherlock (financing and investment products) and included
Homburger advised UBS Group, which, on September 6, 2024 successfully completed its issuance of USD 1.5 billion in aggregate principal amount of fixed rate/fixed rate callable senior notes due September 2045 under its senior debt programme. The Notes
Homburger advised UBS Group on its issuance of USD 1.5 bn of 6.850 per cent Tier 1 capital notes with an equity conversion feature, redeemable at the option of UBS Group after five years. The notes are governed
Advestra advised Galderma on its inaugural bonds in the aggregate principal amount of CHF 500 million. The payment date of the bonds is September 27, 2024. The bonds will be listed on the SIX Swiss Exchange and are
